Latest / The Cracking Cancer Podcast
What Are Tyrosine Kinase Inhibitors (TKIs)? Episode 37.
In this essential episode, host Dr. Kyle Concannon and co-host Samantha Murrell break down the science, promise, and limitations of Tyrosine Kinase Inhibitors (TKIs)—a class of highly effective, usually pill-form, targeted therapy.
Dr. Concannon explains that TKIs are molecular snipers, designed to attack the root cause of cancer by blocking the signaling from a mutated protein (kinase) that causes cells to divide uncontrollably. They clarify the process from DNA blueprint to protein addiction, explaining why these targeted therapies are often more elegant and have fewer side effects than…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.